Preparation and characterization of sustained release pirfenidone loaded microparticles for pulmonary drug delivery: Spray drying approach
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Pirfenidone (PFD) is a drug of choice for the treatment of idiopathic pulmonary fibrosis. For the preparation of sustained release microparticles of PFD, Ethyl cellulose (EC 300) with Eudragit RS 100 in combination was used as encapsulating agents. The 3-level 2-factorial design was employed for the design of experiments (DoE). The spray dried microparticles were studied for their particle size distribution, surface topography, drug entrapment, in-vitro drug release, and aerodynamic performance. Compatibility between drug and excipients were evaluated by Fourier Transform Infrared (FTIR) Spectroscopy and Differential Scanning Calorimetry (DSC). Particle morphology and size distribution were performed using Field Emission Scanning Electron Microscopy (FESEM) and Dynamic light scattering (DLS). The average particle size of the optimized PFD loaded formulation was found to be 3.99 μm. The surface topography study of the optimized formulation showed that the microparticles are nearly spherical with a smooth surface. In addition, the in-vitro aerosol performance was studied by Anderson cascade impactor and developed microparticles showed favorable aerodynamic performance (MMAD 4.25 μm) with narrow particle diameter distribution (GSD 1.52), therefore developed microparticles can be used as a dry powder for inhalation (DPI) for the targeted delivery to the lungs. In conclusion, sustained release microparticles of PFD were successfully prepared by the spray drying technique.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Formulations with a greater proportion of CEM exhibited even higher TrH encapsulation, possibly because the enhanced hydration and viscosity of CEM-rich systems minimized drug leaching into the cross-linking medium during curing.40,61”
Citations
Cites
Design of experiments (DoE) in pharmaceutical development
N. Politis, S., Colombo, P., Colombo, G., & M. Rekkas, D. (2017) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2017.1291672 · Cited by 597 · cited 1×
“ter points, we get an indication of curvature and by replicating center points in design we get an estimation of pure error (standard deviation within the same center points).([14,15]) Table 1 shows details of independent factors with their low ( 1), medium (0), and high levels (þ1) and dependent variables.”
BackgroundDeshmukh, R. K., Wagh, P., & Naik, J. (2016) · Drying Technology · doi:10.1080/07373937.2016.1232271 · Cited by 142 · cited 3×
“properties in the field of pharmaceutics for various applications.([1,2]) Therefore, the spray drying process”
BackgroundSelf-citationPardeshi, C. V., Belgamwar, V. S., Tekade, A. R., & Surana, S. J. (2013) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-013-4965-7 · Cited by 98 · cited 1×
“ism for the drug release through the polymeric matrix.([38]) Statistical analysis: 3(2) full factorial design The 3(2) full factorial design was employed to evaluate the effect of two factors on the specific responses by conducting thirteen experimental trials given by Design-Expert Software.”
MethodTrivedi, R., Redente, E. F., Thakur, A., Riches, D. W. H., & Kompella, U. B. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/50/505101 · Cited by 97 · cited 1×
“excessive fibrosis within the lung parenchyma, characterized by interstitial pneumonia.([7,8]) The drugs avail-”
BackgroundChvatal, A., Ambrus, R., Party, P., Katona, G., Jójárt‐Laczkovich, O., Szabó‐Révész, P., Fattal, E., & Tsapis, N. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.034 · Cited by 87
Statistical Design of Experiments for Screening and Optimization
Lee, R. (2019) · Chemie Ingenieur Technik · doi:10.1002/cite.201800100 · Cited by 85 · cited 1×
“ter points, we get an indication of curvature and by replicating center points in design we get an estimation of pure error (standard deviation within the same center points).([14,15]) Table 1 shows details of independent factors with their low ( 1), medium (0), and high levels (þ1) and dependent variables.”
BackgroundAbnoos, M., Mohseni, M., Mousavi, S. A., Ashtari, K., Ilka, R., & Mehravi, B. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.04.147 · Cited by 77 · cited 5×
“Owing to these disadvantages, PFD is the first anti-fibrotic agent approved by the United States Food and Drug Administration (USFDA) for the effective treatment of IPF.”
BackgroundMethodInfluentialDiclofenac Sodium-Loaded Eudragit® Microspheres: Optimization Using Statistical Experimental Design
Deshmukh, R. K., & Naik, J. (2013) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-013-9167-9 · Cited by 63 · cited 1×
“9360.([35]) Based on the ability to sustained drug release (85.”
BackgroundSelf-citationMahajan, H. S., & Gundare, S. A. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2013.11.036 · Cited by 57 · cited 1×
“The MMAD below 5 lm is good for targeted delivery to the lung and GSD below 3 suggests aerodynamic diameter distribution is narrow.([24,42]) The plot of the inverse standard normal cum distribution versus log effective cut off diameter used two values, one above and one below the 50% cumulative mass and the intersecti…”
MethodAceclofenac microspheres: Quality by design approach
Deshmukh, R. K., & Naik, J. (2014) · Materials Science and Engineering C · doi:10.1016/j.msec.2013.12.024 · Cited by 50 · cited 1×
“In the same way, the increase in Eudragit RS 100 concentration up to the middle level (0), showed maximum drug release retardation and followed the quadratic model.([29,40,41]) The area covered by the yellow region in the overlay plot indicates optimum conditions for the process and their variables, where the entire r…”
BackgroundSelf-citation
Research works printed but not linked: 1
- 10.2147/dddts113670 · doi:10.2147/dddts113670
Cited by
Yun, P., Devahastin, S., & Chiewchan, N. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12701 · Cited by 149
Pardeshi, S. R., Deshmukh, N. S., Telange, D. R., Nangare, S., Sonar, Y. A., Lakade, S. H., Harde, M. T., Pardeshi, C. V., Gholap, A. D., Deshmukh, P. K., et al. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00551-8 · Cited by 122
“The highly concentrated liquid suspensions are converted to powdered form, where the powder characteristics are similar to other solid powder formulations and can be blended into pills, tablets, pellets or easily filled it into capsules [8].”
BackgroundSelf-citationEmerging delivery approaches for targeted pulmonary fibrosis treatment
Diwan, R., Bhatt, H., Beaven, E., & Nurunnabi, M. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115147 · Cited by 89
Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment
Ghumman, M., Dhamecha, D., Gonsalves, A., Fortier, L., Sorkhdini, P., Zhou, Y., & Menon, J. U. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.03.017 · Cited by 79
Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Kole, E. B., Jadhav, K., Shirsath, N. R., Dudhe, P. B., Verma, R. K., Chatterjee, A., & Naik, J. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104261 · Cited by 77
Self-citation
Metadata
- Authors
- Pardeshi, S., Patil, P., Rajput, R., Mujumdar, A., & Naik, J.
- Affiliations
- Kavayitri Bahinabai Chaudhari North Maharashtra University (IN)
- Department of Chemical Engineering, Shri S’ad Vidya Mandal Institute of Technology
- Western University (CA)
- Corresponding author
- Naik, Jitendra
- Venue
- Drying Technology
- Publisher
- Informa UK Limited
- Published
- 2020-10-19
- Volume
- 39
- Issue
- 3
- Pages
- 337-347
- ISSN
- 0737-3937 (ISSN-L)
- 1532-2300
- OpenAlex
- W3105943466
- Cited by
- 37
- References
- 41
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 15 · 2022: 4 · 2021: 5
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drying Technology (publishedVersion)
- Funders
- Technical Education Quality Impprovement Program (DTE/SPFU/2017-18/95)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Life Sciences › Agricultural and Biological Sciences › Food Science › Microencapsulation and Drying Processes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- pirfenidone, sustained drug release, microparticles, pulmonary drug delivery, dry powder inhalation, spray drying, ethyl cellulose, Eudragit RS100, idiopathic pulmonary fibrosis, aerosol performance, particle size distribution, drug encapsulation, drug-excipient compatibility
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preparation and characterization of sustained release pirfenidone loaded microparticles for pulmonary drug delivery: Spray drying approach. https://app.cochat.ai/papers/10.1080/07373937.2020.1833213
- The paper
- Pardeshi, S., Patil, P., Rajput, R., Mujumdar, A., & Naik, J. (2021). Preparation and characterization of sustained release pirfenidone loaded microparticles for pulmonary drug delivery: Spray drying approach. Drying Technology. https://doi.org/10.1080/07373937.2020.1833213
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.